Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance

<p>Early-stage detection of leukemia is a critical determinant for successful treatment of the disease and can increase the survival rate of leukemia patients. The factors limiting the current screening approaches to leukemia include low sensitivity and specificity, high costs, and a low parti...

Full description

Saved in:
Bibliographic Details
Main Author: Ajaz A. Bhat (12984701) (author)
Other Authors: Salma N. Younes (14153241) (author), Syed Shadab Raza (5775911) (author), Lubna Zarif (14152344) (author), Sabah Nisar (12561961) (author), Ikhlak Ahmed (150200) (author), Rashid Mir (2616949) (author), Sachin Kumar (356188) (author), Surender K. Sharawat (12176110) (author), Sheema Hashem (14150961) (author), Imadeldin Elfaki (14153244) (author), Michal Kulinski (3520070) (author), Shilpa Kuttikrishnan (3520079) (author), Kirti S. Prabhu (4246144) (author), Abdul Q. Khan (14153247) (author), Santosh K. Yadav (9364664) (author), Wael El-Rifai (303374) (author), Mohammad A. Zargar (14153250) (author), Hatem Zayed (835448) (author), Mohammad Haris (564809) (author), Shahab Uddin (14150949) (author)
Published: 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513566595350528
author Ajaz A. Bhat (12984701)
author2 Salma N. Younes (14153241)
Syed Shadab Raza (5775911)
Lubna Zarif (14152344)
Sabah Nisar (12561961)
Ikhlak Ahmed (150200)
Rashid Mir (2616949)
Sachin Kumar (356188)
Surender K. Sharawat (12176110)
Sheema Hashem (14150961)
Imadeldin Elfaki (14153244)
Michal Kulinski (3520070)
Shilpa Kuttikrishnan (3520079)
Kirti S. Prabhu (4246144)
Abdul Q. Khan (14153247)
Santosh K. Yadav (9364664)
Wael El-Rifai (303374)
Mohammad A. Zargar (14153250)
Hatem Zayed (835448)
Mohammad Haris (564809)
Shahab Uddin (14150949)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Ajaz A. Bhat (12984701)
Salma N. Younes (14153241)
Syed Shadab Raza (5775911)
Lubna Zarif (14152344)
Sabah Nisar (12561961)
Ikhlak Ahmed (150200)
Rashid Mir (2616949)
Sachin Kumar (356188)
Surender K. Sharawat (12176110)
Sheema Hashem (14150961)
Imadeldin Elfaki (14153244)
Michal Kulinski (3520070)
Shilpa Kuttikrishnan (3520079)
Kirti S. Prabhu (4246144)
Abdul Q. Khan (14153247)
Santosh K. Yadav (9364664)
Wael El-Rifai (303374)
Mohammad A. Zargar (14153250)
Hatem Zayed (835448)
Mohammad Haris (564809)
Shahab Uddin (14150949)
author_role author
dc.creator.none.fl_str_mv Ajaz A. Bhat (12984701)
Salma N. Younes (14153241)
Syed Shadab Raza (5775911)
Lubna Zarif (14152344)
Sabah Nisar (12561961)
Ikhlak Ahmed (150200)
Rashid Mir (2616949)
Sachin Kumar (356188)
Surender K. Sharawat (12176110)
Sheema Hashem (14150961)
Imadeldin Elfaki (14153244)
Michal Kulinski (3520070)
Shilpa Kuttikrishnan (3520079)
Kirti S. Prabhu (4246144)
Abdul Q. Khan (14153247)
Santosh K. Yadav (9364664)
Wael El-Rifai (303374)
Mohammad A. Zargar (14153250)
Hatem Zayed (835448)
Mohammad Haris (564809)
Shahab Uddin (14150949)
dc.date.none.fl_str_mv 2022-11-22T21:18:01Z
dc.identifier.none.fl_str_mv 10.1186/s12943-020-01175-9
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Role_of_non-coding_RNA_networks_in_leukemia_progression_metastasis_and_drug_resistance/21598428
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biological sciences
Genetics
Biomedical and clinical sciences
Oncology and carcinogenesis
Cancer
Circular RNAs
Chromatin
Drug resistance
Epigenetics
Gene regulation
Long non-coding
RNAs
MicroRNAs
Metastasis
Signaling pathways
dc.title.none.fl_str_mv Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p>Early-stage detection of leukemia is a critical determinant for successful treatment of the disease and can increase the survival rate of leukemia patients. The factors limiting the current screening approaches to leukemia include low sensitivity and specificity, high costs, and a low participation rate. An approach based on novel and innovative biomarkers with high accuracy from peripheral blood offers a comfortable and appealing alternative to patients, potentially leading to a higher participation rate.</p> <p>Recently, non-coding RNAs due to their involvement in vital oncogenic processes such as differentiation, proliferation, migration, angiogenesis and apoptosis have attracted much attention as potential diagnostic and prognostic biomarkers in leukemia. Emerging lines of evidence have shown that the mutational spectrum and dysregulated expression of non-coding RNA genes are closely associated with the development and progression of various cancers, including leukemia. In this review, we highlight the expression and functional roles of different types of non-coding RNAs in leukemia and discuss their potential clinical applications as diagnostic or prognostic biomarkers and therapeutic targets.</p><h2>Other Information</h2> <p> Published in: Molecular Cancer<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1186/s12943-020-01175-9" target="_blank">http://dx.doi.org/10.1186/s12943-020-01175-9</a></p>
eu_rights_str_mv openAccess
id Manara2_0febd6324240a42adb43f844bb5657eb
identifier_str_mv 10.1186/s12943-020-01175-9
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/21598428
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Role of non-coding RNA networks in leukemia progression, metastasis and drug resistanceAjaz A. Bhat (12984701)Salma N. Younes (14153241)Syed Shadab Raza (5775911)Lubna Zarif (14152344)Sabah Nisar (12561961)Ikhlak Ahmed (150200)Rashid Mir (2616949)Sachin Kumar (356188)Surender K. Sharawat (12176110)Sheema Hashem (14150961)Imadeldin Elfaki (14153244)Michal Kulinski (3520070)Shilpa Kuttikrishnan (3520079)Kirti S. Prabhu (4246144)Abdul Q. Khan (14153247)Santosh K. Yadav (9364664)Wael El-Rifai (303374)Mohammad A. Zargar (14153250)Hatem Zayed (835448)Mohammad Haris (564809)Shahab Uddin (14150949)Biological sciencesGeneticsBiomedical and clinical sciencesOncology and carcinogenesisCancerCircular RNAsChromatinDrug resistanceEpigeneticsGene regulationLong non-codingRNAsMicroRNAsMetastasisSignaling pathways<p>Early-stage detection of leukemia is a critical determinant for successful treatment of the disease and can increase the survival rate of leukemia patients. The factors limiting the current screening approaches to leukemia include low sensitivity and specificity, high costs, and a low participation rate. An approach based on novel and innovative biomarkers with high accuracy from peripheral blood offers a comfortable and appealing alternative to patients, potentially leading to a higher participation rate.</p> <p>Recently, non-coding RNAs due to their involvement in vital oncogenic processes such as differentiation, proliferation, migration, angiogenesis and apoptosis have attracted much attention as potential diagnostic and prognostic biomarkers in leukemia. Emerging lines of evidence have shown that the mutational spectrum and dysregulated expression of non-coding RNA genes are closely associated with the development and progression of various cancers, including leukemia. In this review, we highlight the expression and functional roles of different types of non-coding RNAs in leukemia and discuss their potential clinical applications as diagnostic or prognostic biomarkers and therapeutic targets.</p><h2>Other Information</h2> <p> Published in: Molecular Cancer<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1186/s12943-020-01175-9" target="_blank">http://dx.doi.org/10.1186/s12943-020-01175-9</a></p>2022-11-22T21:18:01ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1186/s12943-020-01175-9https://figshare.com/articles/journal_contribution/Role_of_non-coding_RNA_networks_in_leukemia_progression_metastasis_and_drug_resistance/21598428CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/215984282022-11-22T21:18:01Z
spellingShingle Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
Ajaz A. Bhat (12984701)
Biological sciences
Genetics
Biomedical and clinical sciences
Oncology and carcinogenesis
Cancer
Circular RNAs
Chromatin
Drug resistance
Epigenetics
Gene regulation
Long non-coding
RNAs
MicroRNAs
Metastasis
Signaling pathways
status_str publishedVersion
title Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
title_full Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
title_fullStr Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
title_full_unstemmed Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
title_short Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
title_sort Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
topic Biological sciences
Genetics
Biomedical and clinical sciences
Oncology and carcinogenesis
Cancer
Circular RNAs
Chromatin
Drug resistance
Epigenetics
Gene regulation
Long non-coding
RNAs
MicroRNAs
Metastasis
Signaling pathways